arrow
P

Paul Yonga

managing editor
H指数:11
被引数:741

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ending nuclear weapons, before they end us

终结核武器,在其毁灭我们之前

2025-12-310
PRE
Ending nuclear weapons, before they end us

终结核武器,在其终结我们之前

2025-09-230
OA
Ending nuclear weapons, before they end us

终结核武器,在其毁灭我们之前

2025-07-160
PRE
Ending Nuclear Weapons, Before They End Us

终结核武器,否则我们将终结自身

2025-07-150
PREAI
Ending nuclear weapons, before they end us

终结核武器,在其终结我们之前

2025-06-120
PREAI
Ending nuclear weapons, before they end us

终止核武器,在其终结我们之前

2025-06-100
PREAI
Yellow Fever in South America – A Plea for Action and Call for Prevention in Travelers from SLAMVI, ESGITM, EVASG, ALEIMC, GEPI-SEIMC, SEMEVI, and CMTZMV-ACIN♦

南美洲的黄热病——来自SLAMVI、ESGITM、EVASG、ALEIMC、GEPI-SEIMC、SEMEVI和CMTZMV-ACIN♦的行动呼吁与旅行者预防呼吁

2025-06-010
OAAI
Ending nuclear weapons, before they end us

终结核武器,以免它们终结我们

2025-05-280
OAAI
Ending nuclear weapons, before they end us

终结核武器,在其终结我们之前

2025-05-190
PRE
Ending nuclear weapons, before they end us

终结核武器,以免它们终结我们

2025-05-190
PRE
Ending nuclear weapons, before they end us

终结核武器,以免它们终结我们

2025-05-190
OA
Ending nuclear weapons, before they end us

终结核武器,以免它们终结我们

2025-05-190
OA
Ending nuclear weapons, before they end us

终结核武器,在其终结我们之前

2025-05-190
OA
Ending nuclear weapons, before they end us

终结核武器,在它们终结我们之前

2025-05-190
OA
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial

羟氯喹或氯喹预防新型冠状病毒肺炎 (COPCOV) 的评估: 一项双盲,随机,安慰剂对照试验

2024-09-121
OAAI